- Oct 31, 2008
- 20,856
- 12,580
- 38
- Country
- United States
- Gender
- Male
- Faith
- Catholic
- Marital Status
- Married
- Politics
- US-Republican
The Supreme Court on Thursday ruled against a challenge to the Food and Drug Administration's (FDA) regulatory approval process of the abortion drug mifepristone, in the latest abortion case since the landmark decision in 2022 that overturned Roe v. Wade.
In a victory for the Biden administration and abortion rights supporters, the high court gave a unanimous decision that challengers to the FDA lacked standing to sue the government.
"Under Article III of the Constitution, a plaintiff's desire to make a drug less available for others does not establish standing to sue. Nor do the plaintiffs' other standing theories suffice," Justice Brett Kavanaugh wrote, who authored the unanimous opinion.
Supreme Court rules in abortion medication case, finds group lacked standing to challenge FDA approval
The Supreme Court on Thursday ruled that challengers the FDA's approval process of the abortion drug mifepristone lacked standing to sue the government.
